CRF1 receptor antagonists for treating congenital adrenal hyperplasia, their pharmaceutical preparations and solid forms

摘要

4 - (4 - (2-chloro-4-methoxy-5-methylphenyl) - N - ((1s) - 2-cyclopropyl-1 - (3-fluoro-4-methylphenyl) ethyl) - 5-methyl-n-prop-2 - IN-1)3 - containing thiazol-2-2 - amine (formula I) or pharmacally acceptable salt thereof;Providing a method associated with the treatment of congenital adrenal hyperplasia in an object requiring it.Solution furtherIn the treatment of congenital adrenal hyperplasia (CAH)4 - (2-chloro-4-methoxy-5-methylphenyl) - N - ((1s) - 2 - cyclopropyl-1 - (3-fluoro-4-methylphenyl) ethyl) - 5-methyl-n-prop-2 - IN-13 - pharmaceutical preparations and solid forms of thiazol-2-amine or pharmaceutically acceptable salt thereofAnd their use is provided.No selection